1. Characterization of an At-Risk Population for Nonalcoholic Fatty Liver Disease (NAFLD) in a Primary Care Setting Along the U.S.–Mexico Border.
- Author
-
Spitz, Lindsay, Saadiq, Stefan, Shokar, Navkiran K., Zuckerman, Marc J., Casner, Nancy A., Valenzuela, Roy, and Salinas, Jennifer J.
- Subjects
- *
METABOLIC syndrome risk factors , *NON-alcoholic fatty liver disease , *MEDICAL protocols , *RISK assessment , *MEXICAN Americans , *NURSES , *MEDICAL care use , *PRIMARY health care , *HISPANIC Americans , *DESCRIPTIVE statistics , *RETROSPECTIVE studies , *DISEASE prevalence , *LONGITUDINAL method , *RESEARCH , *ELECTRONIC health records , *MEDICAL records , *ACQUISITION of data , *MEDICAL screening , *COMPARATIVE studies , *DIABETES , *DISEASE risk factors - Abstract
Introduction: This study aimed to determine the burden of suspected nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in a predominantly Hispanic patient population and explore the utility of the American Gastroenterological Association's NAFLD Clinical Care Pathway (CCP). Methodology: Electronic medical records (n = 223) were used to divide patients into risk groups based on the amount of metabolic risk factors they presented, diabetic status, or if they presented other liver diseases. Fribosis-4 (FIB-4) scores were used to determine the risk for advanced fibrosis. Results: Most patients (83.8%) were considered at risk for NAFLD based on CCP criteria, and about a third of patients (33.2%) were found to be at indeterminate (n = 60; 26.9%) or high risk (n = 14; 6.3%) for advanced fibrosis. Most indeterminate-risk patients (78.3%) were not referred for liver imaging. Discussion: This study demonstrates the potential of the CCP as a corrective tool that could help to better identify and screen patients at risk for NAFLD. [ABSTRACT FROM AUTHOR]
- Published
- 2025
- Full Text
- View/download PDF